Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).

BACKGROUND: Access to tailored HIV prevention services remains limited for West African MSM. We assessed adherence to quarterly HIV prevention services and its impact on HIV incidence in MSM followed up in four cities in Burkina Faso, Côte d'Ivoire, Mali, and Togo.
METHODS: We performed a prospective cohort study between 2015 and 2018. HIV-negative MSM aged over 18 benefited from quarterly medical visits which included a clinical examination, HIV testing, screening and treatment for other sexually transmitted infections, peer-led counselling and support, and the provision of condoms and lubricants. Determinants of adherence to quarterly follow-up visits and incident HIV infections were identified using generalized estimating equation models and Cox proportional hazard models, respectively.
RESULTS: 618 MSM were followed up for a median time of 20.0 months (interquartile range 15.2-26.3). Overall adherence to quarterly follow-up visits was 76.5% (95% confidence interval [CI] 75.1-77.8), ranging from 66.8% in Abidjan to 87.3% in Lomé (p < 0.001). 78 incident HIV infections occurred during a total follow-up time of 780.8 person-years, giving an overall incidence of 10.0 per 100 person-years (95% CI 8.0-12.5). Adherence to quarterly follow-up visits was not associated with the risk of incident HIV infection (adjusted hazard ratio 0.80, 95% CI 0.44-1.44, p = 0.545).
CONCLUSIONS: Strengthening HIV prevention services among MSM in West Africa, including the use of PrEP, will be critical for controlling the epidemic, not only in this key population but also in the general population. Quarterly follow-up of MSM, which is essential for PrEP delivery, appears feasible. TRIAL REGISTRATION: ClinicalTrials.gov, number NCT02626286 (December 10, 2015).

Background

Men who have sex with men (MSM) are disproportionately affected by HIV in Africa and elsewhere [1-3]. In 2018, their risk of acquiring HIV was 22 times higher than that of all male adults. In Western and Central Africa, the HIV epidemic is concentrated in key populations (including MSM, sex workers, and people who inject drugs), which together with their sexual partners represented 64% of all new HIV infections in 2018 [4]. Furthermore, median HIV prevalence in 16 West African countries was 13.7% among MSM compared with 1.5% in the general population. In addition, HIV infection in African MSM contributes to the dynamic of the epidemic [5, 6] because 50–90% of MSM also have sex with women [7, 8].

Since the early 2010s, the World Health Organization (WHO) has recommended targeting MSM as part of the response to the HIV epidemic [9, 10]. More specifically, recommendations encourage healthcare decision-makers to promote routine HIV testing and counselling in this population. MSM are also encouraged to perform HIV retesting at least annually and every three months if they engage in high-risk sexual behaviours. Since 2014, the WHO has also recommended developing comprehensive prevention and care services which not only include the abovementioned HIV testing and counselling but also pre-exposure prophylaxis (PrEP), linkage and enrolment in care, HIV treatment and care, prevention and management of co-infections and other co-morbidities, as well as sexual and reproductive health interventions [11].

Risk factors for HIV acquisition in MSM include high per-act transmission probability of receptive anal sex, high rate of sexually transmitted infections (STI), high frequency of condomless anal sex, high number of male partners, and involvement in large sexual networks [2, 12, 13]. Moreover, MSM in Africa face social and legal barriers (i.e., homophobia, stigmatization, discrimination, violence, and penalization of same-sex relationships) that hinder their access to HIV prevention and care services [14, 15]. Unfortunately, HIV services tailored to their needs are limited and are mostly offered by community-based organizations [16, 17]. Furthermore, in general, HIV-negative MSM come to prevention services when they have a health need (e.g., STI) or for specific needs (e.g., condoms and lubricants).

The CohMSM study was designed to assess the feasibility and interest of implementing quarterly HIV prevention and care services in MSM in West Africa. In the present analysis, we assessed adherence to quarterly prevention services and its impact on HIV incidence in MSM followed up in four West African countries. Our study hypothesis was that high adherence to quarterly prevention services would be associated with lower HIV incidence.

Methods

Study design, setting and participants

A prospective cohort study was performed between June 2015 and January 2018 in Abidjan (Côte d’Ivoire), Bamako (Mali), Lomé (Togo), and Ouagadougou (Burkina Faso). MSM were enrolled and followed up in community-based clinics already providing MSM-specific prevention, care, and support (Clinique de Confiance in Abidjan, Clinique des Halles in Bamako, Centre Lucia in Lomé, and Centre Oasis in Ouagadougou). MSM were eligible if they were aged 18 or over, reported at least one episode of anal intercourse with another man in the previous three months, and were HIV negative (status confirmed at study enrolment). At enrolment and during the quarterly follow-up visits, participants benefited from a clinical examination, HIV testing, screening and treatment for other STI, personalized peer-led counselling and support, and the provision of condoms and lubricants. PrEP was not available. MSM who seroconverted during follow-up were invited to initiate antiretroviral therapy (ART) immediately. Participants could also attend the clinics at any time according to their needs. All services were free of charge. Participants were compensated 3000 Francs CFA (approximately US$5) for transport costs for each scheduled follow-up visit. Socio-demographic and behavioural data were collected at enrolment and every six months thereafter using a standardized face-to-face questionnaire administered by trained research assistants. Finally, with their consent, peer-educators could contact the participants by phone if they were 15 days late for their scheduled visits. The study was discontinued when PrEP was added to the CohMSM cohort. Specifically, the study was performed from June 2015 to January 2018 in Bamako, from October 2015 to January 2018 in Abidjan, from February 2016 to November 2017 in Ouagadougou, and from June 2016 to November 2017 in Lomé.

Laboratory procedures

Screening for HIV was performed according to national algorithms [18-21]. All four study cities first used the Determine HIV 1/2 assay (Abbott Laboratories, Chiba, Japan). Positive results were confirmed using the Bioline HIV-1/2 3.0 assay (SD, Gyeonggi-do, Republic of Korea) in Abidjan, Bamako, and Ouagadougou, or the First Response HIV-1/2 assay (Premier Medical Corporation, Mumbai, India) in Lomé. Samples with discordant results were tested a third time using the HIV 1/2 Stat-Pak assay (Chembio Diagnostics, New York, USA) in Abidjan, the First Response HIV-1/2 assay (Premier Medical Corporation, Mumbai, India) in Bamako, the Inno-Lia HIV I/II Score assay (Fujirebio, Zwijnaarde, Belgium) in Lomé, or a Western Blot assay in Ouagadougou.

Outcomes

Adherence to quarterly follow-up visits

Adherence to quarterly follow-up visits was defined as the proportion of scheduled visits which MSM actually attended (i.e., the number of attended visits divided by the number of scheduled visits). A visit was considered attended when it was carried out at the scheduled date plus or minus 45 days [22]. The period of participation for each participant (hereafter called “observation time”) ended at study discontinuation, first HIV positive screening test, or death.

HIV incidence

Incident HIV infection was defined as a HIV infection detected during follow-up. The date of HIV infection was estimated as the midpoint between the date of the last negative screening test and the date of the first positive one. HIV incidence was calculated per 100 person-years. Follow-up time was calculated from enrolment to HIV infection or the last participant’s HIV screening test.

Explanatory variables

Potential explanatory variables considered in this analysis included: i) socio-demographic characteristics: city, age, education (primary school or higher versus never attended school or koranic school), marital status (married or in free union versus single/divorced/separated/widowed), ii) psychosocial characteristics: self-defined sexual orientation (homosexual or gay/heterosexual/bisexual versus transsexual/transgender), self-identified gender (much more a woman/both a man and a woman/neither man nor woman versus a man or a boy), sexual attraction (to men and women/to women versus to men), received psychological support (yes versus no); iii) sexual behaviours in the previous 6 months: condom use during insertive anal sex (inconsistent, no insertive anal sex versus consistent), condom use during receptive anal sex (inconsistent, no receptive anal sex versus consistent), received payment (whether financial or other) for transactional sex with male partners (sometimes, always versus never), provided payment (whether financial or other) for transactional sex with male partners (sometimes, always versus never), number of male sexual partners (1–5 versus ≥ 6); iv) clinical data: history of HIV screening (no versus yes), STI (other than HIV) symptoms (yes versus no).

Statistical analysis

Adherence to quarterly follow-up visits was calculated overall and according to each study city. The 95% confidence intervals (CI) of adherence were computed using the binomial method. The evolution of adherence during follow-up was assessed using the χ2 test for trend. Determinants of adherence to quarterly follow-up visits were identified using generalized estimating equation models which provide population-averaged estimates while controlling for the correlation of repeated measures for the same individual. Independent variables associated with adherence with a p-value < 0.20 in univariate analyses were selected for the complete multivariate model. A backward elimination procedure based on the quasi-likelihood Akaike’s information criterion was used to determine the final multivariate model.

Cumulative hazards of incident HIV infections were estimated by Kaplan-Meier survival curves and compared between the study cities using the log-rank test. Given the fact that the proportional hazards hypothesis using the Schoenfeld residuals was verified for the most important covariates (i.e., adherence to quarterly follow-up visits and study city), the determinants of incident HIV infections were investigated using Cox regression models. Independent variables associated with incident HIV infections with a p-value < 0.20 in univariate analyses were specified in the complete multivariate model. A manual backward selection based on the log-likelihood method was used to determine the final multivariate model.

For the analyses of both outcomes, we used time-constant and time-dependent variables. The former were collected at enrolment and included the study city, age, educational level, marital status, and history of HIV screening. The latter included self-defined sexual orientation, self-identified gender, sexual attraction, condom use, sexual behaviours, psychological support, and STI (i.e., other than HIV) symptoms.

For all calculations, statistical significance was defined with a p-value < 0.05. All statistical analyses were performed using Stata software (version 15; Stata Corp LP, College Station, Texas). The CohMSM study is registered with ClinicalTrials.gov, number NCT02626286).

Results

Characteristics of participants

A total of 618 HIV-negative MSM were enrolled: 249 (40.3%) in Bamako, 133 (21.5%) in Abidjan, 121 (19.6%) in Ouagadougou, and 115 (18.6%) in Lomé. Their baseline characteristics are described in Table 1. Median age was 23.7 years (interquartile range [IQR] 21.2–27.0). Three hundred and thirty-six (54.5%) participants self-defined as bisexual, and 230 (37.3%) as homosexual/gay. A total of 354 (57.4%) participants self-identified as a man/boy, and 219 (43.6%) as both a man and a woman. The majority of participants (n = 319, 51.8%) were sexually attracted to men. With regard to STI risky behaviours in the previous six months, 185 (30.3%) participants reported inconsistent condom use during insertive anal sex, 206 (33.7%) reported inconsistent condom use during receptive anal sex, and 194 (38.8%) received payment (whether financial or other) for transactional sex with male partners. A large majority of participants (n = 532, 86.1%) had already been tested for HIV before study enrolment. Seventy-eight (12.6%) participants had at least one STI symptom (urethral or anal discharge, genital or anal ulceration, or condyloma) at enrolment.

Table 1

Baseline characteristics of the 618 MSM participants

	All (N = 618)			Bamako (N = 249)			Abidjan (N = 133)			Ouagadougou (N = 121)			Lomé (N = 115)
	N	n	(%)	N	n	(%)	N	n	(%)	N	n	(%)	N	n	(%)	P
Age (years)a	618	23.7	(21.2–27.0)	249	23.4	(21.1–26.3)	133	24.4	(22.1–27.7)	121	23.2	(20.9–26.6)	115	23.6	(20.3–27.3)	0.031
≤ 25		388	(62.8%)		166	(66.7%)		74	(55.6%)		82	(67.8%)		66	(57.4%)	0.065
Educational level	562			227			122			109			104			< 0.001
Never attended school/Koranic		19	(3.4%)		11	(5.4%)		5	(4.1%)		3	(2.7%)		0	–
Primary school		72	(12.8%)		48	(20.5%)		6	(4.9%)		10	(9.2%)		7	(7.7%)
Secondary school		250	(44.5%)		88	(36.6%)		44	(36.1%)		60	(55.1%)		58	(55.8%)
University		221	(39.3%)		80	(37.5%)		67	(54.9%)		36	(33.0%)		38	(36.5%)
Marital status	562			227			122			109			104			< 0.001
Married/free union		100	(17.8%)		20	(8.8%)		64	(52.4%)		9	(8.3%)		7	(6.8%)
Single/divorced/separated/widowed		462	(82.2%)		207	(91.2%)		58	(47.6%)		100	(91.7%)		97	(92.2%)
Self-defined sexual orientation	598			248			131			105			114			< 0.001
Homosexual/gay		230	(38.5%)		70	(28.2%)		54	(41.2%)		41	(39.1%)		65	(57.0%)
Heterosexual		13	(2.2%)		2	(0.8%)		1	(0.8%)		3	(2.9%)		7	(6.1%)
Transsexual/transgender		19	(3.2%)		15	(6.1%)		1	(0.8%)		1	(0.9%)		2	(1.7%)
Bisexual		336	(56.2%)		161	(64.9%)		75	(53.2%)		60	(57.1%)		40	(35.1%)
Self-identified gender	617			248			133			121			115			< 0.001
A man/a boy		354	(57.4%)		147	(59.3%)		61	(45.9%)		63	(52.1%)		83	(72.2%)
Both a man and a woman		179	(29.0%)		67	(27.0%)		45	(33.8%)		43	(35.5%)		24	(20.9%)
Much more a woman		75	(12.1%)		32	(12.9%)		27	(20.3%)		8	(6.6%)		8	(7.0%)
Neither man nor woman		9	(1.5%)		2	(0.8)		0	–		7	(5.8%)		0	–
Sexual attraction	617			248			133			121			115			< 0.001
To men		319	(51.8%)		92	(37.1%)		86	(64.7%)		60	(49.6%)		81	(70.4%)
To men and women		269	(43.6%)		151	(60.9%)		40	(30.1%)		53	(43.8%)		25	(21.7%)
To women		29	(4.7%)		5	(2.0%)		7	(5.3%)		8	(6.6%)		9	(7.87%)
Condom use during insertive anal sexb	610			245			130			121			114			< 0.001
Consistent		190	(31.2%)		72	(29.4%)		36	(27.7%)		46	(38.0%)		36	(31.5%)
Inconsistent		185	(30.3%)		55	(22.4%)		42	(32.3%)		47	(38.9%)		41	(36.0%)
No insertive anal sex		237	(38.5%)		118	(48.2%)		52	(40.0%)		28	(23.1%)		37	(32.5%)
Condom use during receptive anal sexb	611			246			130			121			114			0.278
Consistent		168	(27.5%)		73	(29.7%)		29	(22.3%)		34	(28.1%)		32	(28.1%)
Inconsistent		206	(33.7%)		79	(32.1%)		56	(43.1%)		35	(28.9%)		36	(31.6%)
No receptive anal sex		237	(38.8%)		94	(38.2%)		45	(35.6%)		52	(43.0%)		46	(40.3%)
Received payment (whether financial or other) for transactional sex with male partnersb	611			246			130			121			114			0.144
Never		417	(68.2%)		157	(63.8%)		94	(72.3%)		90	(74.4%)		76	(66.7%)
Sometimes/always		194	(38.8%)		89	(36.1%)		36	(27.7%)		31	(25.6%)		38	(33.3%)
Provided payment (whether financial or other) for transactional sex with male partnersb	611			246			130			121			114			0.055
Never		540	(88.4%)		214	(87.0%)		122	(93.8%)		109	(90.1%)		96	(83.3%)
Sometimes/always		71	(11.6%)		32	(13.0%)		8	(6.2%)		12	(9.9%)		19	(16.7%)
Group sex with male partnersb	611			246			130			121			114			< 0.001
Never		456	(74.6%)		197	(80.1%)		82	(63.1%)		82	(67.8%)		95	(83.3%)
Once		75	(12.3%)		21	(8.5%)		20	(15.4%)		23	(19.0%)		11	(9.7%)
Twice or more		80	(13.1%)		28	(11.4%)		28	(21.5%)		16	(13.2%)		8	(7.0%)
Number of male sexual partnersb	612			247			130			121			114			< 0.001
1		187	(30.5%)		92	(37.2%)		31	(23.8%)		28	(23.1%)		36	(31.6%)
2–5		351	(57.3%)		130	(52.6%)		71	(54.6%)		82	(67.8%)		68	(59.7%)
6–10		54	(8.8%)		18	(7.3%)		20	(14.4%)		9	(7.4%)		7	(6.1%)
> 10		20	(3.3%)		7	(2.8%)		8	(6.2%)		2	(1.7%)		3	(2.6%)
Received psychological support	512	382	(74.6%)	211	147	(69.7%)	113	90	(79.6%)	89	67	(75.3%)	99	78	(78.8%)	0.171
History of HIV screening	618	532	(86.1%)	249	218	(87.6%)	133	113	(85.0%)	121	96	(79.3%)	115	105	(91.3%)	0.054
STI (other than HIV) symptoms	618	78	(12.6%)	249	13	(5.2%)	133	17	(12.8%)	121	37	(30.6%)	115	11	(9.6%)	< 0.001

a Median (interquartile range)

b During the previous 6 months

Adherence to quarterly follow-up visits

Overall adherence to quarterly HIV prevention follow-up visits was 76.5% (95% confidence interval [CI] 75.1–77.8) over a median observation time of 20.0 months (IQR 15.2–26.3). Fifty-one participants (8.3%) never attended the clinics after the enrolment visit, and an additional 52 (8.4%) did not attend at least their last two scheduled follow-up visits. Two other participants died from unknown reasons. Specifically, adherence to quarterly follow-up visits was 87.3% (95% CI 84.0–90.1) over a median observation time of 15.8 months (IQR 14.7–16.6) in Lomé, 78.9% (95% CI 77.0–80.7) over 26.9 months (IQR 21.4–29.3) in Bamako, 73.2% (95% CI 69.4–76.5) over 17.3 months (IQR 14.0–19.5) in Ouagadougou, and 66.8% (95% CI 63.4–70.0) over 23.8 months (IQR 13.1–25.8) in Abidjan.

Adherence to quarterly follow-up visits was highest at month 3 (82.2%) and lowest at month 24 (64.5%; Fig. 1). Overall, it decreased significantly over time (p < 0.001). The decrease was significant in Bamako and Abidjan (p < 0.001 for both) but not in Ouagadougou (p = 0.887) and Lomé (p = 0.730).

Fig. 1

Adherence to quarterly follow-up visits (a) in all study cities (b) according to study city

In multivariate analysis including observation time, adherence to quarterly follow-up visits was significantly higher in Bamako (adjusted coefficient [aβ] 0.17, 95% CI 0.11; 0.22, p < 0.001) and Lomé (aβ 0.15, 95% CI 0.08; 0.21, p < 0.001), but not in Ouagadougou (aβ 0.05, 95% CI − 0.01; 0.12, p = 0.107), than in Abidjan (Table 2). Multivariate analysis also confirmed that adherence decreased with time (aβ − 0.01 per 1-month increase, 95% CI -0.02; − 0.01, p < 0.001). Adherence was not associated with any other participant characteristic.

Table 2

Determinants of adherence to quarterly follow-up visits (generalized estimating equations regressions)

	Univariate analysis			Multivariate analysis
	β	95% CI	P	aβ	95% CI	P
City
Abidjan	Reference			Reference
Bamako	0.13	0.10; 0.17	< 0.001	0.17	0.11; 0.22	< 0.001
Ouagadougou	0.10	0.06; 0.14	< 0.001	0.05	−0.01; 0.12	0.107
Lomé	0.21	0.17; 0.26	< 0.001	0.15	0.08; 0.21	< 0.001
Observation time (per 1-month increase)	− 0.01	− 0.01; − 0.007	< 0.001	-0.01	−0.02; − 0.01	< 0.001
Age (years)
≤ 25	Reference
> 25	−0.01	− 0.04; 0.01	0.288
Educational level
No school/Koranic	Reference
Primary/secondary/university	−0.03	−0.07; 0.02	0.222
Marital status
Single/divorced/separated/widowed	Reference
Married/free union	−0.02	− 0.04; 0.004	0.109
Self-defined sexual orientation
Transsexual/transgender	Reference
Homosexual or gay/heterosexual/bisexual	0.009	−0.03; 0.04	0.620
Self-identified gender
A man/a boy	Reference
Other	−0.001	−0.02; 0.01	0.853
Sexual attraction
To men	Reference
To men and women/to women	0.0004	−0.01; 0.01	0.945
Condom use during insertive anal sexa
Consistent	Reference
Inconsistent	−0.003	− 0.02; 0.01	0.694
No insertive anal sex	−0.002	−0.02; 0.01	0.765
Condom use during receptive anal sexa
Consistent	Reference
Inconsistent	−0.004	−0.02; 0.01	0.615
No receptive anal sex	−0.004	−0.02; 0.01	0.560
Received payment (whether financial or other) for transactional sex with male partnersa
Never	Reference
Sometimes	0.002	−0.01; 0.01	0.760
Always	−0.002	−0.03; 0.03	0.894
Provided payment (whether financial or other) for transactional sex with male partnersa
Never	Reference
Sometimes	−0.0005	−0.02; 0.02	0.955
Always	−0.009	−0.06; 0.08	0.804
Group sex with male partners
Never	Reference
Once	−0.01	−0.04; 0.01	0.170
Twice or more	−0.02	− 0.05; 0.01	0.109
Number of male sexual partnersa
1–5	Reference
≥ 6	−0.0002	−0.01; 0.11	0.968
Received psychological support
No	Reference
Yes	0.007	−0.01; 0.22	0.353
History of HIV screening
Yes	Reference
No	0.05	0.01; 0.09	0.018
STI (other than HIV) symptoms
No	Reference
Yes	−0.004	−0.02; 0.02	0.712

Abbreviations: CI confidence interval, STI sexually transmitted infection

aDuring the previous 6 months

HIV incidence

Seventy-eight participants seroconverted over a total follow-up time of 780.8 person-years, giving an overall HIV incidence of 10.0 per 100 person-years (95% CI 8.0–12.5). Incident HIV infections occurred after a median time of 7.8 months (IQR 3.4–13.5). HIV incidence was 14.4 per 100 person-years (95% CI 9.6–21.7) in Abidjan, 10.2 per 100 person-years (95% CI 5.7–18.5) in Lomé, 9.0 per 100 person-years (95% CI 6.5–12.5) in Bamako, and 7.3 per 100 person-years (95% CI 3.8–14.0) in Ouagadougou. The time of incident HIV infections did not differ significantly between the study cities (p = 0.257; Fig. 2).

Fig. 2

Cumulative probability of incident HIV infections (a) in all study cities (b) according to study city. P-value calculated using the log-rank test

Table 3 shows HIV incidence according to participant characteristics. The risk of incident HIV infection was not significantly associated with adherence to quarterly follow-up visits in either univariate (hazard ratio [HR] 0.69, 95% CI 0.39–1.23, p = 0.209) or multivariate analysis (adjusted hazard ratio [aHR] 0.80, 95% CI 0.44–1.44, p = 0.545). However, it was significantly higher in participants who did not consistently use condoms during insertive anal sex (aHR 3.09, 95% CI 1.52–6.32, p = 0.002) and those who reported no insertive anal sex (aHR 3.77, 95% CI 1.90–7.50, p < 0.001) in the previous six months than in participants who consistently used condoms during insertive anal sex. Finally, it was significantly higher in participants who had never been tested for HIV before study enrolment than in those who had been (aHR 2.48, 95% CI 1.41–4.36, p = 0.002).

Table 3

HIV incidence and determinants of incident HIV infections (Cox models)

	Incident HIV cases/person-years	Incidence/100 person-years (95% CI)		Univariate analysis			Multivariate analysis
				HR	95% CI	P	aHR	95% CI	P
Adherence to quarterly follow-up visits (%)		11.6	(7.1–19.0)	1			1
< 100	16/137.4			0.69	0.39–1.23	0.209	0.80	0.44–1.44	0.545
100	62/643.4	9.6	(7.5–12.4)
City
Abidjan	23/159.8	14.4	(9.6–21.7)	1			1
Bamako	35/389.7	9.0	(6.4–12.5)	0.61	0.36–1.04	0.070	0.67	0.39–1.16	0.156
Ouagadougou	9/123.7	7.3	(3.8–14.0)	0.48	0.22–1.05	0.066	0.49	0.22–1.07	0.073
Lomé	11/107.6	10.2	(5.6–18.5)	0.66	0.31–1.36	0.256	0.90	0.42–1.91	0.783
Age (years)
≤ 25	50/490.4	10.2	(7.7–13.4)	1
> 25	28/290.4	9.6	(6.6–14.0)	0.94	0.59–1.50	0.808
Educational level
No school/Koranic	2/30.4	6.6	(1.6–26.3)	1
Primary/secondary/university	68/727.5	9.3	(7.4–11.8)	1.43	0.35–1.03	0.615
Marital status
Single/divorced/separated/widowed	50/616.1	8.1	(6.1–10.7)	1
Married/free union	20/141.8	14.1	(9.1–21.9)	1.78	1.06–2.99	0.030
Self-defined sexual orientation
Transsexual/transgender	4/17.0	23.6	(8.8–62.7)	1
Homosexual or gay/heterosexual/bisexual	67/740.2	9.1	(7.1–11.5)	0.41	0.15–1.13	0.084
Self-identified gender
A man/a boy	39/475.8	8.2	(6.0–11.2)	1
Other	34/289.7	11.7	(8.4–16.4)	1.44	0.91–2.28	0.123
Sexual attraction
To men	33/407.1	8.1	(5.8–11.4)	1
To men and women/to women	40/366.1	10.9	(8.0–14.9)	1.34	0.84–2.08	0.214
Condom use during insertive anal sexa
Consistent	11/294.3	3.7	(2.1–6.4)	1			1
Inconsistent	27/232.8	11.6	(7.9–16.9)	2.97	2.14–13.31	0.003	3.09	1.51–6.32	0.002
No insertive anal sex	34/242.9	14.0	(10.0–19.6)	3.72	1.97–11.22	< 0.001	3.77	1.90–7.50	< 0.001
Condom use during receptive anal sexa
Consistent	25/222.8	11. 2	(7.6–16.6)	1
Inconsistent	29/207.0	14.0	(9.7–20.2)	1.21	0.91–3.00	0.494
No receptive anal sex	18/340.0	5.3	(3.3–8.4)	0.46	0.23–0.86	0.013
Received payment (whether financial or other) for transactional sex with male partnersa
Never	53/550.3	9.6	(7.4–12.6)	1
Sometimes	16/182.5	8.8	(5.4–14.3)	0.91	0.52–1.60	0.749
Always	3/20.9	14.4	(4.6–44.6)	1.49	0.46–4.77	0.509
Provided payment (whether financial or other) for transactional sex with male partnersa
Never	67/679.2	9.9	(7.8–12.5)	1
Sometimes	5/72.0	6.9	(2.9–16.7)	0.70	0.28–1.74	0.442
Always	0/2.5	–		NC	–	–
Group sex with male partnersa
Never	62/681.0	9.1	(7.1–11.7)	1
Once	6/40.9	14.7	(6.6–32.7)	1.23	0.43–3.47	0.697
Twice or more	4/31.8	12.6	(4.7–33.5)	1.53	0.65–3.61	0.331
Number of male sexual partnersa
1–5	63/687.0	9.2	(7.2–11.7)	1
≥ 6	10/88.0	11.4	(6.1–21.1)	1.26	0.65–2.47	0.494
Received psychological support
No	9/120.1	7.4	(3.9–14.3)	1
Yes	55/608.7	9.0	(6.9–11.8)	1.22	0.60–2.49	0.580
History of HIV screening
Yes	62/695.0	8.9	(7.0–11.4)	1			1
No	16/85.7	18.7	(11.4–30.5)	2.05	1.18–3.57	0.011	2.48	1.41–4.36	0.002
STI (other than HIV) symptoms
No	69/729.4	9.4	(7.5–12.0)	1
Yes	5/50.8	9.8	(4.1–23.7)	1.04	0.42–2.58	0.935

Abbreviations: HR hazard ratio, aHR adjusted hazard ratio, CI confidence interval, NC not calculable, STI sexually transmitted infection

aDuring the previous 6 months

Discussion

This multi-country study conducted in MSM living in West Africa showed good overall adherence to quarterly HIV prevention services, which included HIV testing and counselling, screening and treatment for other STI, and the provision of condoms and lubricants. However, we recorded a decrease in adherence over time as well as differences between the study cities (Abidjan, Bamako, Lomé, and Ouagadougou). Moreover, adherence had no significant impact on HIV incidence, which was high in the study population.

The good overall adherence to quarterly follow-up visits by HIV-negative individuals is encouraging for the implementation of prevention programmes, as MSM commitment is crucial for repeated HIV testing and counselling, screening and treatment for other STI, as well as PrEP (not examined here). Importantly, repeated HIV testing was well accepted by participants and was performed systematically at each visit. The good adherence observed in the study was likely related to the favourable study context, specifically the fact that the study clinics were MSM-friendly, and that peer-educators were very involved in enrolment and retention of MSM in the programme, as well as counselling and psychosocial support [23]. Adherence support for MSM included a reminder telephone call 15 days after an outstanding follow-up visit. This measure was inspired by routine practice in the study clinics, in which medical teams call HIV-positive patients if they are late for scheduled visits. Mobile phones are now widely used throughout Sub-Saharan Africa, and just as is the case for ART, they constitute a useful and affordable tool for maintaining adherence to prevention services. The compensation of US$5 for transport costs for each follow-up visit certainly encouraged adherence. Although the use of financial compensation for routine medical interventions has been debated, its effectiveness has been shown in different contexts [24, 25].

However, two of our findings on adherence to quarterly HIV prevention services call for caution. First, despite having the same study procedures, lower adherence was observed in Abidjan than in Bamako and Lomé, which suggests that the local context (e.g., difficulty and cost of transportation, reluctance/willingness to come to clinics, and spatial and temporal organization of clinics) had an impact. This underlines the need for additional measures adapted to the local context in terms of adherence support for MSM and solutions to overcome organizational constraints in clinics. Second, the observed decrease of adherence over time could be problematic for long-term public health programmes. However, the relatively small proportion of participants lost to follow-up shows that most of the missed visits were accounted for MSM still in the programme. We hypothesize that long-term adherence to follow-up will be better in MSM using PrEP who will need to come to medical visits for supplies.

Despite the good adherence to quarterly prevention services, HIV incidence in our study was far higher than the WHO-recommended threshold of 3 per 100 person-years, which defines populations at substantial risk and who should be offered PrEP [26]. Our figure was comparable with those from other African studies in which incidence was 6.8 per 100 person-years (95% CI 4.9–9.2) and 8.6 per 100 person-years (95% CI 6.7–11.0) in two different studies in Kenya, and 16.0 per 100 person-years (95% CI 4.6–27.4) and 15.4 per 100 person-years (95% CI 12.3–19.0) in studies in Senegal and Nigeria, respectively [13, 27–29]. Although HIV incidence did not differ statistically between the four study cities, our data confirm that it was especially high in Abidjan, reflecting findings in CohMSM’s pilot study in 2013–2015 (15.9 per 100 person-years, 95% CI 7.6–33.4) [30]. In a previous analysis, we found that MSM at greater risk of exposure to HIV infection decreased their risky sexual behaviours during their follow-up in CohMSM, suggesting a potential positive effect of the quarterly prevention services on those who need it most [31]. However, the high HIV incidence and the lack of association between adherence to these services and incident HIV infections observed in the present analysis strongly suggest that this intervention alone is insufficient to significantly reduce the burden of the epidemic in this population. This may be due to the fact that most HIV infections occurred in the first months of follow-up while changes in sexual behaviours require more time and are rarely optimal. These data confirm the need to strengthen HIV prevention services through the use of PrEP.

In our study, some participants did not attend the quarterly follow-up visits because they had moved elsewhere, either temporarily or permanently. Only when participants moved from one study city to another - which was quite common in the study population - could they continue their follow-up in the second study clinic. This underscores the need to establish a network of intra-country and inter-country MSM-friendly clinics in West Africa (and elsewhere) for sustainable prevention.

A major challenge for the control of HIV infection in MSM is to reach and test those who have never been tested. In our study, these men were at greater risk of acquiring HIV infection. A recent study in neighbouring Nigeria reported a similar finding [13]. The relationship between condom use during insertive anal sex and incident HIV infections reflects existing evidence, as inconsistent condom use is a well-known risk factor and most participants who reported no insertive anal sex also reported receptive anal sex.

The main strength of this study is the fact that it was conducted in four West African countries, which allowed us to highlight differences in the outcomes between all four. However, our findings have the following limitations. First, our participants might not be fully representative of the global MSM community in the four study cities because the study was performed in MSM enrolled and followed up in MSM-friendly community-based clinics. Second, the study was performed in the major cities of Burkina Faso, Côte d’Ivoire, Mali, and Togo and our results may not be generalizable to other contexts of these countries. Third, the duration of the study differed between countries due to the staggered start of the study and the staggered discontinuation of the study. Finally, a social desirability bias may have affected participants’ responses (e.g., regarding condom use).

Conclusions

This multi-country study clearly demonstrates that strengthening HIV prevention services among MSM in West Africa will be critical for controlling the epidemic, not only in this key population but also in the general population. Fortunately, West African countries are currently reviewing their national guidelines and are planning to integrate PrEP into their prevention services. This study’s results suggest that quarterly follow-up of MSM, which is essential for PrEP delivery, is feasible.